Jackson Creek Investment Advisors’s Astrana Health ASTH Stock Holding History

Jackson Creek Investment Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26M	Buy	+35,417	New	+$1.27M	0.42%	93

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jackson Creek Investment Advisors's ASTH Position: Q2 2026 in Review

Jackson Creek Investment Advisors opened a new position in Astrana Health (ASTH) in Q2 2026: 35,417 shares worth $1.26M. The stake represents 0.42% of the portfolio and ranks #93 among its holdings.

209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Jackson Creek Investment Advisors held 35,417 shares of Astrana Health worth $1.26M as of Q2 2026.
Astrana Health was a new Jackson Creek Investment Advisors position in Q2 2026.
Astrana Health made up 0.42% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #93 holding.
209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.